Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension. [electronic resource]
Producer: 20200728Description: 376-383 p. digitalISSN:- 1931-3543
- Adult
- Antihypertensive Agents -- therapeutic use
- Atrial Remodeling
- Cardiac Catheterization
- Drug Therapy, Combination
- Echocardiography
- Epoprostenol -- analogs & derivatives
- Female
- Humans
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Peptide Fragments -- blood
- Phenylpropionates -- therapeutic use
- Pulmonary Arterial Hypertension -- blood
- Pyridazines -- therapeutic use
- Retrospective Studies
- Risk Reduction Behavior
- Tadalafil -- therapeutic use
- Treatment Outcome
- Vascular Resistance
- Vasodilator Agents -- therapeutic use
- Ventricular Function, Right
- Ventricular Remodeling
- Walk Test
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.